Stay updated on Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial page.
Latest updates to the Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial page
- Check4 days agoChange DetectedRevision history updated: added v3.3.4 and removed v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded a comprehensive Locations section listing numerous sites across the US and internationally and removed older per-state location groupings. The update updates where the study is conducted and how sites are presented on the page.SummaryDifference1%
- Check54 days agoChange DetectedThe Publications section now explains that publications are automatically filled from PubMed, and the page displays Revision: v3.3.2; the previous PubMed wording and Revision: v3.2.0 have been replaced.SummaryDifference0.1%
- Check61 days agoChange DetectedRemoved the government funding status notice banner from the page, with the rest of the study details remaining visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check75 days agoChange DetectedNo substantive changes to the study page were detected between the two screenshots; core content such as study design, eligibility criteria, primary and secondary outcomes, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check104 days agoChange DetectedUpdated operating-status notice and version 3.2.0; removed version 3.1.0.SummaryDifference2%
Stay in the know with updates to Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Once vs Twice Weekly Carfilzomib in Multiple Myeloma Clinical Trial page.